Drug Safety Podcast on Feedspot

Drug Safety Podcast

583 FOLLOWERS

The FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER). They provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. Here you'll find the latest US Food and Drug Administration news and information.

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

6d ago

Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions ..read more

Visit website

FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

3w ago

Listen to an audio podcast of the April 13, 2023, FDA Drug Safety Communication, FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use ..read more

Visit website

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

6M ago

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab ..read more

Visit website

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

11M ago

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma ..read more

Visit website

FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

11M ago

Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL ..read more

Visit website

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

1y ago

Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast Media ..read more

Visit website

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

1y ago

Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses ..read more

Visit website

FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

1y ago

Listen to an audio podcast of the January 12, 2022, FDA Drug Safety Communication warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth ..read more

Visit website

FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

1y ago

“Listen to FDA Drug Podcast, FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury ..read more

Visit website

FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions

Drug Safety Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

1y ago

Listen to an audio podcast of the September 1, 2021 FDA Drug Safety Communication on requiring revisions to the Boxed Warning for Xeljanz/Xeljanz XR, Olumiant, and Rinvoq to include information about the risks of serious heart-related events, cancer, blood clots, and death ..read more

Visit website

Follow Drug Safety Podcast on Feedspot